NASDAQ:RPID Rapid Micro Biosystems (RPID) Stock Price, News & Analysis $2.61 -0.03 (-1.14%) Closing price 04:00 PM EasternExtended Trading$2.60 -0.01 (-0.57%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rapid Micro Biosystems Stock (NASDAQ:RPID) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Rapid Micro Biosystems alerts:Sign Up Key Stats Today's Range$2.51▼$2.7250-Day Range$1.36▼$3.9052-Week Range$0.58▼$4.04Volume227,489 shsAverage Volume173,097 shsMarket Capitalization$112.85 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingStrong Buy Company OverviewRapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Read More… Remove Ads Rapid Micro Biosystems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreRPID MarketRank™: Rapid Micro Biosystems scored higher than 34% of companies evaluated by MarketBeat, and ranked 782nd out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageRapid Micro Biosystems has only been the subject of 1 research reports in the past 90 days.Read more about Rapid Micro Biosystems' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($1.10) to ($0.94) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rapid Micro Biosystems is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rapid Micro Biosystems is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRapid Micro Biosystems has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Rapid Micro Biosystems' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.78% of the float of Rapid Micro Biosystems has been sold short.Short Interest Ratio / Days to CoverRapid Micro Biosystems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rapid Micro Biosystems has recently increased by 190.28%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRapid Micro Biosystems does not currently pay a dividend.Dividend GrowthRapid Micro Biosystems does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.78% of the float of Rapid Micro Biosystems has been sold short.Short Interest Ratio / Days to CoverRapid Micro Biosystems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rapid Micro Biosystems has recently increased by 190.28%, indicating that investor sentiment is decreasing significantly. News and Social Media2.7 / 5News Sentiment0.93 News SentimentRapid Micro Biosystems has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Rapid Micro Biosystems this week, compared to 1 article on an average week.Search InterestOnly 5 people have searched for RPID on MarketBeat in the last 30 days. This is a decrease of -72% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Rapid Micro Biosystems to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.Percentage Held by Insiders30.40% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Rapid Micro Biosystems' insider trading history. Receive RPID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address RPID Stock News HeadlinesIs Rapid Micro Biosystems Inc. (RPID) the Popular Penny Stock on Robinhood to Watch?March 27, 2025 | msn.comIs Rapid Micro Biosystems (RPID) One of the Penny Stocks With Huge Upside Potential According to Analysts?March 23, 2025 | insidermonkey.comTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.April 1, 2025 | Porter & Company (Ad)Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 12, 2025 | globenewswire.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | insidermonkey.comRapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call TranscriptMarch 2, 2025 | seekingalpha.comRapid Micro Biosystems stock tumbles on earnings miss, weak outlookFebruary 28, 2025 | in.investing.comRapid Micro Biosystems Shares Rise in Premarket on New Distribution Agreement with MerckFebruary 28, 2025 | marketwatch.comSee More Headlines RPID Stock Analysis - Frequently Asked Questions How have RPID shares performed this year? Rapid Micro Biosystems' stock was trading at $0.90 at the beginning of 2025. Since then, RPID shares have increased by 190.0% and is now trading at $2.61. View the best growth stocks for 2025 here. How were Rapid Micro Biosystems' earnings last quarter? Rapid Micro Biosystems, Inc. (NASDAQ:RPID) posted its quarterly earnings data on Friday, February, 28th. The company reported ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.22). The business had revenue of $8.22 million for the quarter, compared to analyst estimates of $8.20 million. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative trailing twelve-month return on equity of 48.05%. When did Rapid Micro Biosystems IPO? Rapid Micro Biosystems (RPID) raised $125 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share. How do I buy shares of Rapid Micro Biosystems? Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rapid Micro Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rapid Micro Biosystems investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Advanced Micro Devices (AMD), Black Stone Minerals (BSM), Essex Property Trust (ESS), Iovance Biotherapeutics (IOVA) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings2/28/2025Today4/01/2025Next Earnings (Estimated)5/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:RPID CIK1380106 Webwww.rapidmicrobio.com Phone978-349-3200FaxN/AEmployees200Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+206.5%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-52,470,000.00 Net Margins-184.93% Pretax Margin-184.78% Return on Equity-48.05% Return on Assets-39.18% Debt Debt-to-Equity RatioN/A Current Ratio5.52 Quick Ratio4.19 Sales & Book Value Annual Sales$28.05 million Price / Sales4.02 Cash FlowN/A Price / Cash FlowN/A Book Value$2.78 per share Price / Book0.94Miscellaneous Outstanding Shares43,237,000Free Float29,952,000Market Cap$112.85 million OptionableNot Optionable Beta1.08 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:RPID) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapid Micro Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapid Micro Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.